Research programme: antibody - AskGene Pharma
Alternative Names: Antibody - AskGene PharmaLatest Information Update: 27 Oct 2021
At a glance
- Originator AskGene Pharma
- Class Antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 21 Oct 2021 AskGene Pharma files an IND application with the regulatory body in China for Unspecified indication
- 21 Oct 2021 AskGene Pharma plans a clinical trial for Unspecified indication in China (Parenteral)
- 01 Oct 2021 AskGene Pharma in-licenses Leap-In Transposase technology from ATUM, before October 2021